Typhoid vaccine oral - AcambisAlternative Names: CVD 908-htrA; HolaVax-Typhoid
Latest Information Update: 12 Oct 2006
At a glance
- Originator Acambis
- Mechanism of Action Immunostimulants
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
Highest Development Phases
- Discontinued Typhoid
Most Recent Events
- 12 Oct 2006 Discontinued - Phase-II for Typhoid in USA (PO)
- 12 May 2004 Suspended - Phase-II for Typhoid in USA (PO)
- 05 Feb 2004 The HolaVax-Typhoid vaccine is available for licensing (http://www.acambis.com)